A Simple and Robust Vector-Based shRNA Expression System Used for RNA Interference

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wang, Xue jun ^a   Li, Ying ^a   Huang, Hai ^a   Zhang, Xiu juan ^a   Xie, Pei wen ^a   Hu, Wei ^a   Li, Dan dan ^a   Wang, Sheng qi ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DETERMINATION; DRUG EFFECT; GENE EXPRESSION; GENE SILENCING; HEPATITIS B; HEPATITIS B VIRUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROMOTER REGION; REPORTER GENE; RNA INTERFERENCE; RNA STRUCTURE; RNA VECTOR; SCREENING TEST; SEQUENCE ANALYSIS;

ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GENETIC ENGINEERING; GENETIC VECTORS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84873533812     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056110     Document Type: Article

References (24)

1. Meister G, Tuschl T, (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431: 343-349.
2. Sibley CR, Seow Y, Wood MJ, (2010) Novel RNA-based strategies for therapeutic gene silencing. Molecular therapy: the journal of the American Society of Gene Therapy 18: 466-476.
3. Brummelkamp TR, Bernards R, Agami R, (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
4. Khurana A, Tun HW, Marlow L, Copland JA, Dredge K, et al. (2012) Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell lines. Mol Carcinog 51: 565-575.
5. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, et al. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124: 1283-1298.
6. Root DE, Hacohen N, Hahn WC, Lander ES, Sabatini DM, (2006) Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 3: 715-719.
7. Chen YC, Su WC, Huang JY, Chao TC, Jeng KS, et al. (2010) Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A. Journal of virology 84: 7983-7993.
8. Xu XM, Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL, (2009) Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression. Nature protocols 4: 1338-1348.
9. Chumakov SP, Kravchenko JE, Prassolov VS, Frolova EI, Chumakov PM, (2010) Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector. Plasmid 63: 143-149.
10. Chen CC, Ko TM, Ma HI, Wu HL, Xiao X, et al. (2007) Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. Gene therapy 14: 11-19.
11. Wu HL, Huang LR, Huang CC, Lai HL, Liu CJ, et al. (2005) RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 128: 708-716.
12. Sun D, Rosler C, Kidd-Ljunggren K, Nassal M, (2010) Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites. J Hepatol 52: 817-826.
13. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, et al. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
14. Flores-Jasso CF, Velazquez-Quesada I, Landa-Solis C, Gutierrez AA, Vaca L, (2005) One-oligonucleotide method for constructing vectors for RNA interference. Acta Pharmacol Sin 26: 1467-1473.
15. Li XX, Jia HW, Quan JX, Jiao YL, Yang YH, et al. (2008) An efficient approach for constructing shRNA expression vectors based on short oligonucleotide synthesis. Analytical biochemistry 381: 163-165.
16. Miyagishi M, Sumimoto H, Miyoshi H, Kawakami Y, Taira K, (2004) Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells. The journal of gene medicine 6: 715-723.
17. Li L, Lin X, Khvorova A, Fesik SW, Shen Y, (2007) Defining the optimal parameters for hairpin-based knockdown constructs. RNA 13: 1765-1774.
18. Starega-Roslan J, Krol J, Koscianska E, Kozlowski P, Szlachcic WJ, et al. (2011) Structural basis of microRNA length variety. Nucleic acids research 39: 257-268.
19. McIntyre GJ, Yu YH, Lomas M, Fanning GC, (2011) The effects of stem length and core placement on shRNA activity. BMC molecular biology 12: 34.
20. Xu Y, Hu Y, Shi B, Zhang X, Wang J, et al. (2009) HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Molecular immunology 46: 2640-2646.
21. Cui J, Fu H, Feng J, Zhu J, Tie Y, et al. (2007) The construction of miRNA expression library for human. Prog Biochem Biophys 34: 389-394.
22. Hu W, Wang X, Ding X, Li Y, Zhang X, et al. (2012) MicroRNA-141 represses HBV replication by targeting PPARA. PloS one 7: e34165.
23. Chen A, Dong L, Leffler NR, Asch AS, Witte ON, et al. (2011) Activation of GPR4 by acidosis increases endothelial cell adhesion through the cAMP/Epac pathway. PloS one 6: e27586.
24. McLaughlin J, Cheng D, Singer O, Lukacs RU, Radu CG, et al. (2007) Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proceedings of the National Academy of Sciences of the United States of America 104: 20501-20506.